China’s National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody from UK ...

WuXi Biologics has signed a deal with Sino Biopharm to develop a first-in-class monoclonal antibody targeting an undisclosed ...

Full mergers and acquisitions in the pharmaceutical and biotechnology in 2024 fluctuated throughout the year with hardly any in some months and a significant number in other. But one thing was clear – ...

PrimeGene raises $46 million in a series B round to advance Phase III trials and regulatory filings for pumecitinib, its atopic dermatitis treatment. Funds will also support pipeline expansion and IPO ...

39-43 Putney High Street, Putney London, SW15 1SP United Kingdom ...